PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects
Clinical trial NCT02130414 · COMPLETED
Trial details
- NCT number
- NCT02130414
- Sponsor
- Sigmoid Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-01-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.